Pubblicazioni

Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS

2021 - THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM

Tsourdi, E.; Zillikens, M. C.; Meier, C.; Body, J. -J.; Gonzalez Rodriguez, E.; Anastasilakis, A. D.; Abrahamsen, B.; Mccloskey, E.; Hofbauer, L. C.; Guanabens, N.; Obermayer-Pietsch, B.; Ralston, S. H.; Eastell, R.; Pepe, J.; Palermo, A.; Langdahl, B.

Efficacy of denosumab therapy following treatment with bisphosphonates in women with osteoporosis: A cohort study

2021 - INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH

Marocco, C.; Zimatore, G.; Mocini, E.; Fornari, R.; Iolascon, G.; Gallotta, M. C.; Bimonte, V. M.; Baldari, C.; Lenzi, A.; Migliaccio, S.

Positioning novel biologicals in CKD-mineral and bone disorders

2017 - JN. JOURNAL OF NEPHROLOGY

Tartaglione, Lida; Pasquali, Marzia; Rotondi, Silverio; Muci, MARIA LUISA; Covic, Adrian; Mazzaferro, Sandro

The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study

2015 - OSTEOPOROSIS INTERNATIONAL

Papapoulos, S; Lippuner, ; Roux, C; Lin, C. J. F.; Kendler, D. L.; Lewieck, E. M.; Brandi, M. L.; CzerwiÅski, E.; Franek, E.; Lakatos, P.; Mautalen, C.; Minisola, Salvatore; Reginster, J. Y.; Jensen, S.; Daizadeh, N. S.; Wang, A.; Gavin, M.; Libanati, C.; Wagman, R. B.; Bone, H. G.